SCHEMBL11565382

SCHEMBL11565382

Cc1cccc(C)c1Nc1ccc2ccccc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
CYP3A4 P08684 2/20 0.57
HSD17B10 Q99714 2/20 0.57
HPGD P15428 1/20 0.57
HIF1A Q16665 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAPGEF4 Q8WZA2 6/20 0.45
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
PKM P14618 2/20 0.44
PKLR P30613 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP2A6 P11509 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
DHODH Q02127 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22848405 0.87 RAPGEF4 (0.60) ALDH1A1CYP3A4HSD17B10HPGDRAPGEF4
SCHEMBL22848171 0.84 ALDH1A1 (0.52) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL20344275 0.81 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL1011046 0.81 ALDH1A1 (0.57) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL15273014 0.80 ALDH1A1 (0.52) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL3631643 0.79 RAPGEF4 (0.59) ALDH1A1RAPGEF4MEN1KMT2A
SCHEMBL4278475 0.79 ALDH1A1 (0.72) ALDH1A1HPGDRAPGEF4
SCHEMBL182655 0.79 ALDH1A1 (0.86) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL3739909 0.79 ALDH1A1 (0.86) ALDH1A1CYP3A4HSD17B10HPGDHIF1A
SCHEMBL29386674 0.79 ALDH1A1 (0.86) ALDH1A1CYP3A4HSD17B10HPGDHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220388944-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2022-12-08 US disclosed
WO-2021120835-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS 陕西莱特光电材料股份有限公司 2021-06-24 WO disclosed
US-4159983-A Pure and substantially pure asymmetric 1:2 cobalt complexes of monoazo compounds SANDOZ LTD. (CH) 1979-07-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220388944-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALDH1A1 1303/4885CYP3A4 1077/4885HSD17B10 3274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.